JOSHUA H. LEVINE
PRESIDENT AND CHIEF EXECUTIVE OFFICER
Joshua H. Levine joined Accuray in October 2012 as President and Chief Executive Officer, and Director of the Board. Levine brings extensive experience from a career spanning three decades in the medical device/medical technology industry, having worked in a variety of market-leading organizations including American Hospital Supply, Kinetic Concepts (KCI), Mentor, Johnson & Johnson and Immucor.
Levine served as President and CEO of Mentor Corporation from 2004 through early 2009 and led the company through a strategic transformation prior to its sale to Johnson & Johnson. Levine spent a total of 15 years at Mentor, where he held various Sales, Marketing and Management roles including Chief Operating Officer and Senior Vice President of Global Sales and Marketing. Most recently, he served as President and CEO of Immucor Corporation. Levine holds a Bachelor of Arts degree in Communications from the University of Arizona and has completed Executive Management Programs at Stanford University, Graduate School of Business and the University of Pennsylvania, Wharton School.
CORPORATE SENIOR VICE PRESIDENT, CHIEF COMMERCIAL OFFICER
Lionel Hadjadjeba is Corporate Senior Vice President, Chief Commercial Officer at Accuray. In this role, he leads the global sales, service and marketing teams along with the medical and scientific affairs team. Hadjadjeba brings more than 25 years of experience in the pharmaceutical and medical device industries, holding executive positions in sales, marketing, clinical research, health economics and general management. Hadjadjeba joined Accuray in 2012 as Senior Vice President of International Business and General Manager of EIMEA. He was promoted to President World Wide Commercial in 2015 before taking on his current role as Chief Commercial Officer in 2017.
Prior to Accuray, Hadjadjeba was employed by Haemonetics Corporation, a publicly traded global provider of blood and plasma supplies and services, from May 2010 to October 2012, most recently as their President EMEALARI. Before Haemonetics, Hadjadjeba held various executive positions at Life Technologies Corporation, a publicly traded biotechnology company that was acquired by Thermo Fisher Scientific, from May 2007 to April 2010, most recently as their President and General Manager, EMEA. From 2005 to 2007, he was part of the International Medtronic team in Tolochenaz, Switzerland and served as Vice President of the Spinal, Biologics and Navigations divisions and as Chief Executive Officer of Sofamor SNC, a company that was acquired by Medtronic. A medical doctor by training, Hadjadjeba began his career at Lilly France as a medical representative and market research analyst.
Hadjadjeba earned his M.D. from the University of Nancy in France and his MBA from HEC Paris.
SENIOR VICE PRESIDENT, CHIEF FINANCIAL OFFICER
Kevin Waters serves as the Chief Financial Officer, having joined Accuray in September 2015. He brings more than a decade of medical device experience and 15 years of financial experience. In his role as CFO, Waters leads the global finance, financial planning and investor relations functions of Accuray. He is also responsible for overseeing the company’s facilities. Waters joined Accuray in October 2013 as Senior Vice President, Finance. During his career, Waters has demonstrated significant expertise and leadership in turnaround and high-growth management situations for publicly-held global medical technology companies.
Prior to joining Accuray, Waters was employed for more than seven years by Conceptus Inc., a global leader in the development and commercialization of innovative device-based solutions in permanent birth control, and was most recently Vice President of Finance, prior to its acquisition by Bayer Healthcare in September 2013. Before Conceptus, Waters was Corporate Controller at Laserscope, Inc., a manufacturer of urology and aesthetic laser products. Prior to this, Waters held various finance leadership positions at VISX, a manufacturer of laser vision correction technologies. Waters began his professional career at PricewaterhouseCoopers, LLP.
Waters earned his B.S. in Business Administration, with a double concentration in Finance and Accounting, from Cal Poly San Luis Obispo.
SENIOR VICE PRESIDENT, REGULATORY, QUALITY AND COMPLIANCE
Darl Moreland joined Accuray in August 2013 as Senior Vice President, Regulatory, Quality and Compliance (RQC). In this role, he has worked to establish the RQC organization as a major part of the overall scalability and sustainability efforts currently underway at Accuray. Previously, Moreland led Quality and Compliance departments at several companies including Alexza Pharmaceuticals and Mentor Corporation.
During his career, Moreland has either participated in or has lead teams supporting global approval of numerous pharmaceutical, biotech, combination and medical device products, including two “first in class” products, at companies such as ALZA, Eli Lilly and Company, Guidant, and Mentor.
Moreland earned a B.A. degree in chemistry from Indiana University Purdue University at Indianapolis.
SENIOR VICE PRESIDENT, GENERAL COUNSEL AND CORPORATE SECRETARY
Alaleh Nouri has served as Accuray Senior Vice President, General Counsel and Corporate Secretary since August 2014. In this role she is responsible for all functions of the legal department including corporate governance, board relations, compliance programs, litigation management and contract negotiations. Ms. Nouri joined Accuray in December 2010 as Vice President, Associate General Counsel and assumed the role of Interim General Counsel in February 2014.
Prior to joining Accuray, Ms. Nouri served as Corporate Counsel at Mirion Technologies, Inc., a provider of radiation detection and monitoring services. Ms. Nouri started her career as an associate at the law firm of Orrick, Herrington & Sutcliffe LLP.
Ms. Nouri holds a Bachelors of Commerce degree with specializations in International Business and Finance from the University of British Columbia in Canada and a J.D. from the University of California, Hastings College of Law.
SENIOR VICE PRESIDENT, GLOBAL OPERATIONS AND R&D
Andy Kirkpatrick is the Senior Vice President, Global Operations and R&D at Accuray, bringing more than 20 years of experience in the medical device and technology industries. In his role, Kirkpatrick provides leadership for the company’s global operations, including manufacturing, supply chain and logistics. He is also responsible for overseeing Accuray’s research and development organization. Kirkpatrick joined Accuray in 2007, serving as Vice President, Business Development and has also served as General Manager, Americas region, and Senior Vice President, Global Operations and Corporate Development before taking on his current role.
Prior to joining Accuray, Kirkpatrick held multiple leadership positions at KLA-Tencor and other semiconductor equipment companies in Product Marketing and Manufacturing Operations, Business Development, and Mergers and Acquisitions. Kirkpatrick began his professional career as a nuclear engineer and submarine officer in the U.S. Navy.
Kirkpatrick earned his Masters in Business Administration from the University of California, Walter A. Haas School of Business, and a Bachelor of Science in Mechanical Engineering from the United States Naval Academy.
SENIOR VICE PRESIDENT, CORPORATE DEVELOPMENT
Robert Hill is the Senior Vice President of Corporate Development at Accuray, with responsibility for mergers, acquisitions, partnerships and intellectual property development. Hill served as head of Research and Development and was the company’s Chief Product Officer, prior to taking on his current role in November 2017. His demonstrated expertise in the radiation oncology arena has led to increasing responsibilities during his tenure at Accuray which began in 2007 as Senior Director, Treatment Planning Systems and ultimately to his leadership of the Research and Development organization seven years later.
Prior to joining the company, Hill served as Vice President of Engineering at North American Scientific. He also held various R&D leadership and software development roles at NOMOS Corporation, where he was an early innovator in the fields of Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT), serial tomotherapy, and Monte Carlo dose calculation.
Hill earned a Bachelor of Science degree in Computer Engineering from Carnegie Mellon University.